메뉴 건너뛰기
Annals of Hematology
Volumn 86, Issue 12, 2007, Pages 919-921
Refractory multiple myeloma treated with homoharringtonine: Report of two cases
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; AP PROTOCOL 2; ARSENIC TRIOXIDE; CARMUSTINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HARRINGTONINE DERIVATIVE; HOMOHARRINGTONINE; MELPHALAN; ORGANOARSENIC DERIVATIVE; OXIDE; PREDNISONE; THALIDOMIDE; UNCLASSIFIED DRUG; VAD PROTOCOL; VINCRISTINE; VINDESINE;
EID: 40949131535     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-007-0331-5     Document Type: Letter
Times cited : (7)
References (5)
  • 1
    • 0036884062 scopus 로고    scopus 로고
    • Molecular mechanisms of novel therapeutic approaches for multiple myeloma
    • Hideshima T, Anderson KC (2002) Molecular mechanisms of novel therapeutic approaches for multiple myeloma. Nat Rev Cancer 2:927-937
    • (2002) Nat Rev Cancer , vol.2 , pp. 927-937
    • Hideshima, T.1    Anderson, K.C.2
  • 2
    • 33746105303 scopus 로고    scopus 로고
    • Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia
    • Jin J, Jiang DZ, Mai WY, Meng HT, Qian WB, Tong HY et al (2006) Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia. Leukemia 20:1361-1367
    • (2006) Leukemia , vol.20 , pp. 1361-1367
    • Jin, J.1    Jiang, D.Z.2    Mai, W.Y.3    Meng, H.T.4    Qian, W.B.5    Tong, H.Y.6
  • 3
    • 0030051722 scopus 로고    scopus 로고
    • Homoharringtonine in patients withmyelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia
    • Feldman EJ, Seiter KP, Ahmed T, Baskind P, Arlin ZA (1996) Homoharringtonine in patients withmyelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia. Leukemia 10:40-42
    • (1996) Leukemia , vol.10 , pp. 40-42
    • Feldman, E.J.1    Seiter, K.P.2    Ahmed, T.3    Baskind, P.4    Arlin, Z.A.5
  • 4
    • 0028787176 scopus 로고
    • Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase
    • O'Brien S, Kantarjian H, Keating M, Beran M, Koller C, Robertson LE et al (1995) Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase. Blood 86:3322-3326
    • (1995) Blood , vol.86 , pp. 3322-3326
    • O'Brien, S.1    Kantarjian, H.2    Keating, M.3    Beran, M.4    Koller, C.5    Robertson, L.E.6
  • 5
    • 5444238462 scopus 로고    scopus 로고
    • Homoharringtonine: A new treatment option for myeloid leukemia
    • Luo CY, Tang JY, Wang YP (2004) Homoharringtonine: a new treatment option for myeloid leukemia. Hematology 9:259-270
    • (2004) Hematology , vol.9 , pp. 259-270
    • Luo, C.Y.1    Tang, J.Y.2    Wang, Y.P.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.